Cargando…
Efficacy and safety of Lian-Hua Qing-Wen granule for COVID-2019: A protocol for systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Since the outbreak, the disease has caused more than 60,502 deaths worldwide. Lian-Hua Qing-Wen Granule (LHQWG) is widely used in treating COVID-19 in Chin...
Autores principales: | Hu, Zhipeng, Yang, Maoyi, Xie, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306389/ https://www.ncbi.nlm.nih.gov/pubmed/32501972 http://dx.doi.org/10.1097/MD.0000000000020203 |
Ejemplares similares
-
Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining
por: Shi, Mingfei, et al.
Publicado: (2021) -
The efficacy and safety of qiming granule in dry eye disease: Protocol for systematic review and meta-analysis
por: Yang, Maoyi, et al.
Publicado: (2019) -
Effects of qiming granule for diabetic macular edema: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2019) -
Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2020) -
Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells
por: Li, Qi, et al.
Publicado: (2020)